Skip to main content
. 2021 Feb 4;13(4):611. doi: 10.3390/cancers13040611

Table 1.

Therapies which down-regulate YAP/TAZ activity.

Drug Target Mechanism
Verteporfin YAP Up-regulates 14-3-3
Dasatinib Tyr inhibitor Promotes proteasomal degradation of YAP/TAZ
Pazpanib Tyr inhibitor Promotes proteasomal degradation of YAP/TAZ
Cerivastin HMGCoA reductase Cytoplasmic sequestration of YAP/TAZ
XAV939 Tankynase Decreased YAP/TAZ-mediated expression
Statins HMGCoA reductase Cytoplasmic sequestration of YAP/TAZ
C19 Activates MST1 and LATS1
MF-438 SCD1